Volume | 0 |
|
|||||
Actualités | - |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
SAB Biotherapeutics Inc | SABSW | NASDAQ | Warrant |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,0295 |
Transactions Totales | Volume échangé | Volume en moyenne |
---|---|---|
0 | 0 | - |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
- | 0 | 0,0295 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
1,54M | 52,32M | - | 2,24M | -42,19M | -0,81 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités SAB Biotherapeutics
Date | Heure | Source | Titre |
---|---|---|---|
05/2/2025 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
28/1/2025 | 13:11 | Edgar (US Regulatory) | Form 8-K - Current report |
05/11/2024 | 22:41 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
09/9/2024 | 14:21 | Edgar (US Regulatory) | Form 8-K - Current report |
30/5/2024 | 23:15 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
21/5/2024 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
20/5/2024 | 23:45 | GlobeNewswire Inc. | SAB Biotherapeutics Announces Q1 2024 Financial Results and.. |
20/5/2024 | 22:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
06/5/2024 | 13:15 | GlobeNewswire Inc. | SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of.. |
16/4/2024 | 13:15 | GlobeNewswire Inc. | SAB Biotherapeutics Provides SAB-142 Trial Update |
08/4/2024 | 13:15 | GlobeNewswire Inc. | SAB Biotherapeutics to Present at INNODIA Annual Meeting |
04/4/2024 | 13:15 | GlobeNewswire Inc. | SAB Biotherapeutics to Present at the Needham Virtual.. |
Forum SAB Biotherapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
6 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 an | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 ans | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
5 ans | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:SABSW -
What is the current SAB Biotherapeutics Inc share price?
The current share price of SAB Biotherapeutics Inc is US$ 0,0295
How many SAB Biotherapeutics Inc shares are in issue?
SAB Biotherapeutics Inc has 52 319 000 shares in issue
What is the market cap of SAB Biotherapeutics Inc?
The market capitalisation of SAB Biotherapeutics Inc is USD 1,54M
What is the 1 year trading range for SAB Biotherapeutics Inc share price?
SAB Biotherapeutics Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of SAB Biotherapeutics Inc?
The price to earnings ratio of SAB Biotherapeutics Inc is -2,17
What is the cash to sales ratio of SAB Biotherapeutics Inc?
The cash to sales ratio of SAB Biotherapeutics Inc is 40,89
What is the reporting currency for SAB Biotherapeutics Inc?
SAB Biotherapeutics Inc reports financial results in USD
What is the latest annual turnover for SAB Biotherapeutics Inc?
The latest annual turnover of SAB Biotherapeutics Inc is USD 2,24M
What is the latest annual profit for SAB Biotherapeutics Inc?
The latest annual profit of SAB Biotherapeutics Inc is USD -42,19M
What is the registered address of SAB Biotherapeutics Inc?
The registered address for SAB Biotherapeutics Inc is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the SAB Biotherapeutics Inc website address?
The website address for SAB Biotherapeutics Inc is www.sab.bio
Which industry sector does SAB Biotherapeutics Inc operate in?
SAB Biotherapeutics Inc operates in the BLANK CHECKS sector